Recently, cardiac imaging techniques that evaluate myocardial viability on the basis of myocardial perfusion, cell membrane integrity, and metabolic activity have gained substantial popularity and clinical success. These methods provide greater precision in this assessment than can be achieved by analysis of coronary anatomy, regional function, or the presence or absence of electrocardiographic Q waves. This review will focus on the application of these imaging techniques to address myocardial viability in patients with hibernating or stunned myocardium.
T he differentiation of viable from nonviable myocardium in patients with coronary artery disease and left ventricular dysfunction is an issue of increasing clinical relevance in the current era of myocardial revascularization. It is now well established that impaired left ventricular function does not always represent an irreversible process. However, until recently, determining whether impaired regional or global left ventricular function at rest was a potentially reversible process could be made only retrospectively, after the patient had undergone coronary artery angioplasty or bypass surgery.1-6 Because enhanced left ventricular function after revascularization is associated with improved survival,7-9 diagnostic procedures that identify reversible asynergy prospectively may provide significant prognostic information. Thus, the accurate distinction between viable and scarred or necrotic myocardium has important clinical implications, especially in patients who are being considered for interventional therapy.
In the past, coronary artery patency and preserved regional contractile function were used to identify viable myocardium. However, the inadequacy of an occluded epicardial coronary artery to predict nonviable myocardium was realized when coronary collateral circulation was shown to be capable of sustaining myocardial function at rest10-12 and even during exercise.12-14 Conversely, a patent coronary artery after thrombolytic therapy is insufficient evidence that the dysfunctional myocardium perfused by this artery is viable.15 Electrocardiographic criteria for viability are also imprecise. Although left ventricular function after revascularization is more likely to improve in patients with non-Q wave rather than Q wave infarctions,16 electrocardiographic Q wave criteria are not specific for determining the extent of scarred or viable myocardium after myocardial infarction. 3, [17] [18] [19] Similarly, both animal and clinical studies have also demonstrated that regional myocardial contractile function does not reliably distinguish viable myocardium from nonviable myocardium. [20] [21] [22] [23] [24] It has been shown that under certain conditions, when viable myocytes are subjected to ischemia, prolonged alterations in myocyte function leading to regional left ventricular dysfunction may occur and that this dysfunction may be completely reversible. [25] [26] [27] Conditions that may pose diagnostic difficulties in terms of myocardial viability include 1) patients with left ventricular dysfunction secondary to chronic hypoperfusion, termed hibernating myocardium,25 and 2) patients who have experienced a recent acute coronary syndrome with reperfusion, termed stunned myocardium. 26 In each of these situations, viable myocardium will demonstrate reduced contractility and will be difficult to differentiate from scarred or necrotic myocardium.
Recently, cardiac imaging techniques that evaluate myocardial viability on the basis of myocardial perfusion, cell membrane integrity, and metabolic activity have gained substantial popularity and clinical success. These methods provide greater precision in this assessment than can be achieved by analysis of coronary anatomy, regional function, or the presence or absence of electrocardiographic Q waves. This review will focus on the application of these imaging techniques to address myocardial viability in patients with hibernating or stunned myocardium.
Hibernating Myocardium
Hibernating myocardium refers to chronic left ventricular regional dysfunction arising from prolonged myocardial hypoperfusion in which myocytes remain viable but contraction is chronically depressed. 25 Although the mechanism responsible for the depressed contractile function has not been established, this may be a protective response of the myocytes to reduce oxygen demand in the setting of reduced oxygen availability, thereby establishing perfusion-contraction matching. 28 However, there are no adequate animal models of hibernation, and there are no serial studies in patients that show whether hibernating myocardium is truly a chronic condition. It is conceivable that some cases of hibernation may represent stunning, whereas others may represent silent ischemia. The recovery of regional and global left ventricular function at rest after revascularization in a large subset of patients with chronic left ventricular dysfunction ( Figure 1) of improvement after revascularization. Among 31 patients studied with preoperative asynergy at rest, six of seven (86%) patients with enhanced global left ventricular ejection fraction after surgery had shown postextrasystolic potentiation. However, 10 of 24 (42%) patients without such postoperative improvement in ventricular function also had postextrasystolic potentiation on the preoperative study.17 Because of the variability in timing of premature beats, some experimental studies have suggested that there may be a direct correlation between shortness of the coupling interval to the premature beats and augmentation of contractility, thereby creating the potential for over-or underestimation of postoperative recovery. Potential augmentation of left ventricular contraction pattern in asynergic regions has also been studied during a constant infusion of epinephrine (1-4 ,ug/min) and immediately after exercise.1831 In 1982, Rozanski et al18 reported a significant predictive association between the preoperative wall motion response of asynergic regions after cessation of exercise and subsequent improvement in wall motion after operation. In their study, 91% of regions with reversible asynergy after exercise improved after surgery, whereas 84% of regions with nonreversible asynergy after exercise had persistent wall motion abnormalities postoperatively. Although enhanced regional left ventricular function during nitroglycerin administration,29,30 during postextrasystolic potentiation,'7,32 during low-dose catecholamine infusion,3' or immediately after exercise'8 has been proposed to more accurately identify viable myocardium in patients with chronic regional asynergy, the application of these modalities during contrast or radionuclide ventriculography has yet to gain widespread clinical enthusiasm. More recently, the use of low-dose dobutamine infusions during echocardiography has gathered considerable interest. This will be discussed later in this review.
201T1 Scintigraphy
Thallium myocardial imaging has been established as a clinically important method with which to assess perfusion and sarcolemmal integrity and hence, to address myocardial viability. As the uptake of`0'Tl by myocardial cells is an active process and is dependent on regional blood flow, thallium scintigraphy has the rather unique potential for distinguishing viable from scarred myocardium with greater precision than can be achieved by the assessment of regional anatomy or function.
Regional thallium activity on redistribution images, acquired either early (3-4 hours) or late (8-72 hours) after stress, has been used to demonstrate the distribution of viable myocardial cells and the extent of myocardial fibrosis. Rest-redistribution thallium imaging has also been used successfully in the past to distinguish viable from nonviable myocardium. More recently, thallium reinjection after stress-redistribution imaging has been proposed for identifying viable myocardium. Advantages and disadvantages of stress-early redistribution, late (8-72-hour) redistribution, rest-redistribution, and reinjection methods for viability assessment are discussed below.
Stress-Early Redistribution Imaging
In the initial clinical experience with Tl, two separate injections were used: one during maximal exercise, to demonstrate heterogeneous blood flow under maximal flow conditions between normal and stenosed coronary arteries, and the other at rest. Because of the long half-life of`0Tl and the relatively high residual activity, rest and exercise studies were performed 1-2 weeks apart.
In 1977, Pohost and coworkers33 reported that thallium defects on immediate postexercise images may normalize or redistribute if images were repeated several hours after the initial stress study. This was followed by several experimental animal studies showing that redistribution on a delayed image represented an absolute reduction in thallium concentration in the normal segments along with an absolute increase in thallium concentration in ischemic segments.33-35 Subsequent to these publications, the acquisition of redistribution images 3-4 hours after stress became the standard for exercise thallium scintigraphic studies. However, further experience indicated that there are limitations of stress-3-4-hour redistribution imaging in differentiating viable from fibrotic myocardium.
Normal thallium uptake with exercise and thallium defects that redistribute on 3-4-hour delayed images are accurate indicators of viable myocardium. However, the converse, reduced or absent thallium uptake during stress and lack of redistribution on delayed images, does not necessarily indicate myocardial scar, because severely ischemic but viable myocardium as well as admixture of scar and viable myocardium may also produce an irreversible thallium defect. In 1978, Blood and associates36 reported discordant results between conventional delayed images after exercise and images obtained shortly after thallium is injected at rest. Thallium defects were present in 56% of redistribution images in contrast to only 32% of images after a resting thallium injection (p<0.01). In 17 patients with discordant results between the two methods, 16 had thallium defects on conventional delayed images but not on the separate rest studies. These results were subsequently confirmed by Ritchie and coworkers.37 In keeping with these findings, it is also well established that a large number of myocardial regions with irreversible thallium defects on stress-redistribution imaging will manifest normal thallium uptake after revascularization.38-42 Gibson and associates38 demonstrated, using thallium quantitation, that 45% of segments with irreversible defects had improved thallium uptake after coronary artery bypass surgery ( Figure 2 Figure 4 . That myocardial regions with enhanced thallium uptake after reinjection represent viable myocardium has been supported by two studies in which regional thallium uptake during exercise and resting regional wall motion improved after revascularization in 80 Considering the logistical concerns of performing reinjection imaging in all patients after 3-4-hour redistribution imaging, many laboratories have adopted the routine practice of performing reinjection imaging instead of 3-4-hour redistribution imaging. This approach assumes that the stress-reinjection protocol provides the necessary information regarding both exercise-induced ischemia and myocardial viability. However, it must be emphasized that there are limitations in not performing redistribution images.
Elimination of the 3-4-hour redistribution images and reliance on reinjection images alone may incorrectly assign up to 25% of reversible thallium defects to be irreversible and scarred.45,57 Stress-induced defects that appear to fill in on redistribution images may appear to wash out after reinjection. This results from a disproportionately smaller increment in regional thallium activity after reinjection in some ischemic regions compared with the uptake in normal regions, a phenomenon we have termed "differential uptake."45'57 Unlike conventional redistribution imaging, in which washout reflects an actual net loss of thallium activity between stress and redistribution imaging, it is the low differential uptake of thallium after reinjection that is responsible for the appearance of washout. In a recent study in which four sets of thallium SPECT images were acquired (stress, redistribution, reinjection, and late [24-hour] redistribution), 25% of perfusion defects that redistributed at 3-4 hours appeared to be irreversible when only the stress and reinjection images were compared.57 However, 24-hour images obtained after reinjection demonstrated further redistribution in these regions resulting in relative thallium activities that were indistinguishable from those observed on the 3-4-hour redistribution images ( Figure  5 ). Hence, elimination of the 3-4-hour redistribution images and reliance on reinjection images alone would overestimate myocardial fibrosis in a substantial number of ischemic myocardial regions. However, a stressreinjection protocol appears to be a reasonable alternative to stress-redistribution-reinjection imaging, as long as 24-hour imaging is performed in those patients with persistent irreversible defects on stress-reinjection studies. Thus, these data suggest that two imaging options, stress-early redistribution-reinjection or stress-reinjection-late redistribution imaging, appear to provide comparable information for identifying most of the ischemic but viable myocardial regions.
To circumvent acquiring three sets of images, some investigators have proposed performing an early thallium reinjection immediately after the stress images are obtained. This would allow for redistribution of both the stress and early reinjected thallium doses over the next 3-4 hours and thereby incorporate the information of 3-4-hour redistribution and reinjection studies in a single image. However, the only published results using this approach were unsuccessful.58 Rest-Redistribution Imaging
Because of the logistical problems in performing three sets of thallium images in all patients as well as the problem in interpreting the results if only one set of images is obtained after the stress images (either redistribution without reinjection or reinjection without redistribution), it would be reasonable to perform thallium imaging with resting injections of the isotope if the clinical question to be addressed is one of myocardial viability, not exercise-induced ischemia. However, such an approach will lose the additional diagnostic and prognostic information provided by exercise studies.
Gewirtz et al59 were first to report that thallium defects may occur on resting images in patients with severe coronary artery disease in the absence of an acute ischemic process or previous myocardial infarction. They also recognized that many of these defects redistribute over the next 2-4 hours, especially in regions with normal or hypokinetic wall motion. This initial report was followed by three studies that have evaluated the efficacy of rest-redistribution imaging in predicting the outcome of myocardial regions after revascularization.60-62 These three studies were consistent in showing that the majority (77-86%) of regions with reversible thallium defects preoperatively have normal thallium uptake and/or improved left ventricular function postoperatively. However, these studies were also consistent in demonstrating that 22-67% of regions with irreversible defects also improve after revascularization. Hence, the available data suggest that although rest-redistribution thallium imaging identifies viable myocardium in the majority of reversible regions, it may underestimate viable myocardium in up to two thirds of irreversible regions.
More recently, improved results were obtained using quantitative analysis. When the severity of reduction in thallium activity was considered within irreversible rest-redistribution thallium defects, 65% of akinetic regions that were viable by thallium demonstrated improved wall motion postoperatively compared with only 22% of akinetic regions that were considered to be nonviable by thallium. 63 Similarly, preliminary data obtained from patients undergoing both stress-redistribution-reinjection and rest-redistribution imaging, using quantitative analysis, suggest that the two imaging protocols provide comparable information regarding myocardial viability in the majority of regions. However, rest-redistribution thallium imaging underestimated vim ability in 13% of severely reduced (<50% of normal activity) thallium defects, representing 2% of all myocardial regions studied. 64 Figure 7 .
These findings were confirmed in the second study by Tamaki et a189 in which thallium reinjection identified viable myocardium in 42%_ of regions that were irreversible on 3-4-hour redistribution images. Furthermore, the concordance of viable or nonviable myocardium for thallium reinjection and PET was 85%, with all regions that were reversible on reinjection images also determined to be viable by PET. It is noteworthy that 25% of regions that remained irreversible after reinjection were also identified to be viable by PET. However, thallium activity was not quantitated in this study to evaluate the severity of the irreversible thallium defects, and it is possible that the level of thallium activity within these defects or the magnitude of differential uptake might have provided additional evidence that these regions were viable.
Comparison of Metabolic PET Imaging With Rest-Redistribution SPECT Imaging There are only limited data comparing rest-redistribution thallium imaging with PET imaging using FDG. Brunken et a186 observed a small number of patients with irreversible thallium defects after resting thallium injections who had preserved metabolic activity, suggesting that PET might be superior to rest-redistribution thallium images. Unlike the FDG data, which were assessed quantitatively, the thallium data were analyzed visually, and this difference in methodology could contribute to the apparent superiority of PET in this study. Preliminary data using a quantitative approach to the thallium images suggest that rest-redistribution thallium imaging may provide viability information that is comparable to that obtained by either stress-redistribution-reinjection imaging or PET imaging with FDG. 64 Considering these similarities, either thallium protocol might yield clinically satisfactory information. However, if there are no contraindications to stress testing, stressredistribution-reinjection imaging provides a more comprehensive assessment of the extent and severity of coronary artery disease by demonstrating regional myocardial ischemia without jeopardizing information on myocardial viability. Advantages and Disadvantages of PET and SPECT PET provides enhanced image resolution and routine correction for body attenuation, thereby overcoming the two major limitations that plague thallium imaging: poor image resolution and photon attenuation. In addition, PET provides the capacity to noninvasively quantitate regional blood flow and assess regional metabolic activity independent of flow. Given the technical superiority of PET over SPECT, PET would appear to be the preferred technique for accurate assessment of both perfusion and metabolism in patients with coronary artery disease and left ventricular dysfunction. However, there are other considerations unrelated to technology and cost-effectiveness that might favor the use of exercise thallium scintigraphy.
Stress-redistribution-reinjection thallium imaging provides a more comprehensive evaluation of the presence and extent of exercise-induced myocardial ischemia. In most circumstances, the presence of inducible myocardial ischemia in a patient with ventricular dysfunction is a much more significant clinical variable in terms of patient management and risk assessment than the knowledge of myocardial viability. Furthermore, in patients with chronic severe coronary artery and left ventricular dysfunction, over 70% of myocardial regions manifesting FDG-blood flow mismatch have thallium redistribution on their stress-3-4-hour redistribution Thallium uptake in the early postinfarction period may be useful in estimating the extent of myocardial salvage. Maddahi and colleagues"4 performed thallium imaging in dogs undergoing experimental coronary occlusion using intravenous injections during occlusion and intracoronary injections after reperfusion. After 30 minutes of coronary artery occlusion, the reperfused myocardium had normal thallium uptake. In contrast, in persistently occluded coronary artery vascular territories, the absence of thallium uptake correlated with myocardial necrosis as assessed by histochemical staining. These investigators obtained similar results in patients with acute infarction studied 2.5 hours and 5 hours from onset of symptoms to reperfusion. Intracoronary thallium images immediately after reperfusion showed normal or improved thallium uptake in the 2.5-hour patient group along with recovery of regional function (Figure 8 ). In contrast, irreversible thallium abnormalities associated with persistent wall motion abnormalities were observed in the 5-hour patient group, which persisted up to 10 days thereafter."14 Similar findings were reported by Markis et all"s in patients studied before and after intracoronary streptokinase infusion. If a severe thallium defect remains irreversible even with intracoronary thallium injection after thrombolytic therapy, it is highly predictive of no further improvement at 10 days to 3 months. 116 Despite the close correlation between thallium uptake after reperfusion and subsequent improvement in regional wall motion, early postreperfusion thallium uptake appears to overestimate myocardial viability.
Because the injection of thallium in these studies '14 (prethrombolytic) images are dismissed and thallium is tent of myocardial salvage could be overestimated because of hyperemia. To circumvent the later problem, late imaging after thrombolysis has been advocated. '25 By delaying the second image acquisition to 24 hours or later, the trapping of thallium in the hyperemic phase postreperfusion is avoided. Others have proposed predischarge submaximal exercise thallium scintigraphy to determine both the extent of myocardial salvage and presence of residual myocardial ischemia in the infarctrelated vascular territory.1"6"'9 Thus, pre-and postthrombolytic thallium scintigraphy appears to be a useful, noninvasive method of assessing myocardial salvage and ischemia in patients experiencing acute myocardial infarction.
82Rb Imaging
Myocardial uptake of 12Rb, a short-lived, generatorproduced cation, reflects active cation transport processes across the sarcolemma as well as regional blood flow. Experimental studies using 82Rb have shown that the tracer is taken up by both viable and necrotic myocardium but is not retained by necrotic myocardium. 126 In regions of myocardial fibrosis, the activity of 82Rb is more severely reduced than in regions of viable myocardium demonstrating regional asynergy. In the setting of acute myocardial infarction and reperfusion, similar to`01T1, initial 82Rb uptake will reflect restored blood flow. However, in regions with necrotic tissue, leakage of the tracer will ensue, resulting in a rubidium defect.
Based on these observations, recent studies by Gould et al '27 have suggested that the kinetics of rubidium washout may be used as an index of myocardial viability. Applying such analyses of washout kinetics in patients with acute myocardial infarction, they showed that "2Rb provides information regarding myocardial viability comparable with that achieved by PET imaging with FDG.127 This suggests that myocardial viability early after myocardial infarction may be evaluated either by the behavior of potassium analogues such as 20`T1 and 12Rb as indexes of cell membrane integrity or by measures of metabolic activity.
Metabolic Imaging
In a canine model, Schwaiger et al"28 demonstrated that reperfusion after experimental coronary artery occlusions of 3-hour duration resulted in altered kinetics and delayed clearance of 1`C-palmitate from myocardium, suggesting reduced fatty acid utilization. However, "C-palmitate kinetics do not reflect specific fatty acid metabolic pathways but rather reflect the overall metabolic function. When '4C-palmitate was used in a reperfused, working swine heart model, Liedke et al129 demonstrated that fatty acid oxidation actually increases during early reflow.
Glucose metabolism during reperfusion has also been evaluated by PET with FDG. Although the kinetics of glycolysis during myocardial reperfusion is not completely understood, early studies have suggested that the recovery is rapid and returns to either aerobic levels130 or is modestly increased.13' Both Myears et al13' and Renstrom et al132 have shown that the increased rate of glucose utilization in reperfused hearts contributes only modestly to overall oxidative metabolism. Similarly, administered after thrombolytic therapy, then the exoxidation of pyruvate and lactate also remained de-pressed in the early reperfusion period.133 The attenuated or depressed utilization of glucose and/or its intermediates could be the result of competitive inhibition caused by the preferred oxidation of fatty acids. 133 Schwaiger et al2'8 found that FDG activity remained depressed after reperfusion but was elevated at 24 hours after reperfusion. However, because FDG is unable to completely track the glycolytic and glycogen synthesis pathways, estimates of glucose metabolism using FDG might have been spuriously high in Schwaiger's study.
In 13 patients with acute anterior myocardial infarction studied by PET within 72 hours after the onset of their acute symptoms, metabolic imaging with FDG was able to differentiate viable from nonviable myocardium in regions with decreased blood flow and impaired contraction.134 All regions determined to have matched reduction in perfusion and metabolism in the early postinfarction period manifested either no change or a deterioration in regional function when reassessed 6.0+4.6 weeks later by two-dimensional echocardiography. However, despite this excellent negative predictive accuracy, the positive predictive accuracy was less impressive. Among regions determined to have perfusionmetabolism mismatch, only 50% demonstrated spontaneous improvement of function. This suggests that metabolic imaging with FDG identifies necrotic myocardium accurately but may substantially overestimate the presence and extent of viable myocardium. These clinical data are supported by the findings of Sebree et a1135 in rabbits undergoing coronary occlusion and reperfusion. Myocardial concentrations of '4C-deoxyglucose and`01T1 in macroautoradiograms were correlated quantitatively with evidence of myocardial necrosis by light microscopy in a 24-hour reperfusion group. Discordance between accumulation of 1'C-deoxyglucose and thallium was observed in reperfused myocardium; many myocardial regions with severe hypoperfusion by thallium and histological evidence of necrosis had deposition of 14C-deoxyglucose. The mechanism responsible for FDG uptake in recently infarcted myocardium is not clearly understood and requires further study.
PET imaging using`1C-acetate has recently emerged as another means to evaluate regional myocardial metabolism.`1C-acetate is taken up in proportion to blood flow, and its washout rate is directly related to oxidative tricarboxylic acid cycle flux. [136] [137] [138] Investigators have demonstrated in two separate studies that preservation of myocardial oxidative metabolism using 14C-labeled acetate is predictive of restoration of mechanical function after an acute ischemic event'36 and also predictive of functional recovery after myocardial revascularization in patients with recent myocardial infarction. 139 However, in another study of patients with reperfused anterior myocardial infarction investigated between 2 weeks and 3 months after the acute event, regional oxidative metabolism assessed by '1C-acetate was reduced in proportion to residual myocardial blood flow.138 Furthermore, regional oxidative metabolism did not differ among similarly hypoperfused segments with and without perfusion-metabolism mismatch. The authors concluded that because regional oxidative metabolism is intimately coupled to myocardial blood flow, it is unlikely that it will provide additional independent information in terms of myocardial viability beyond that of residual blood flow and glucose metabolism.'38 The available data, taken together, indicate that recovery of metabolic disturbances precedes recovery of mechanical function in patients exhibiting stunned myocardium. These studies suggest that PET assessment of regional metabolic activity may be useful in predicting residual myocardial viability after reperfusion in patients with acute myocardial infarction. The most accurate PET indexes of viable myocardium in this setting and the metabolic mechanisms underlying these indexes are the subjects of ongoing investigation.
Future Directions of Assessing Hibernating and Stunned Myocardium Dobutamine Echocardiography
Previously ischemic, stunned myocardium can be identified after the administration of inotropic agents such as dopamine, isoproterenol, and dobutamine'40-'50 as well as by postextrasystolic potentiation140,141,145 (Table 2). Response of reperfused, stunned myocardium to inotropic stimulation has been reported largely in animal models,140-'45 with relatively limited experience in human subjects. [146] [147] [148] [149] [150] Experimental Regions that exhibited improvement in systolic function during dobutamine infusion in the acute phase of the study had restored regional function several months later. In contrast, regions that remained akinetic or dyskinetic during dobutamine infusion had persistent regional contraction abnormalities on the later study. Thus, the use of low-dose dobutamine infusions to enhance regional systolic contraction during two-dimensional echocardiography appears to be a promising and readily available technique to identify stunned versus necrotic myocardium in the first week after reperfusion therapy for acute myocardial infarction.
Whether low-dose dobutamine echocardiography will be similarly efficacious in the evaluation of the hibernating myocardium is uncertain, as adequate animal models of hibernation are lacking to test this hypothesis and as there have been no definitive clinical trials reported to date using this method in patients with chronic coronary artery disease and left ventricular dysfunction. Although contractile reserve may be unmasked by low-dose catecholamine infusions in stunned myocardium in which coronary flow has been restored, this may not translate into the ability to demonstrate such contractile reserve in regions rendered dysfunctional by chronic underperfusion. In patients with critically stenosed coronary arteries (with reduction in coronary blood flow so severe at rest as to produce sustained regional contractile dysfunction), the administration of a positive inotropic agent (even at low doses) may merely increase myocardial demand in the setting of exhausted coronary flow reserve, thereby producing myocardial ischemia and persistent regional dysfunction. Despite this conceptual limitation, recent echocardiography may be an accurate predictor of functional recovery after revascularization in patients with chronic left ventricular dysfunction.'5' This study involved only 10 patients and short-term follow-up periods (mean, 7 days). Thus, the application of dobutamine echocardiography to the identification of hibernating myocardium is a potentially exciting approach but one that clearly requires further study.
99mTc-Labeled Perfusion Agents
The use of the two new technetium-based perfusion agents, 9'9Tc-sestamibi and 9'Tc-teboroxime, for viability assessment is another area of interest and uncertainty. Similar to 20'Tl, both are taken up by the myocardium in proportion to regional blood flow, and recent studies have indicated that the accuracy of both agents for detecting coronary artery disease is analogous to that of 20'Tl.152, 153 Myocardial uptake of sestamibi uptake differs from that of thallium. Unlike the transport of thallium, which (like potassium) requires predominantly active transport systems,'54"155 the mechanism of sestamibi uptake may be related to its lipophilicity. In animal models, several investigators have demonstrated that the uptake and retention of sestamibi requires intact cell membrane and mitochondrial membrane processes. In 1989, Meerdink and Leppo'56 demonstrated that myocardial uptake of sestamibi is not active, and that sestamibi extraction continues despite significant metabolic disturbances for as long as cell membrane and mitochondrial processes are intact.156 Using cultured myocardial cells, Piwnica-Worms et al'57 also showed that the uptake of sestamibi is passive across mitochondrial membranes but at equilibrium it is retained within the mitochondria due to a large negative transmembrane potential. Transcapillary transport and myocardial retention of both thallium and sestamibi are in turn affected by the perfusion rate, capillary permeability, and by the binding characteristics within the myocardium.156'58 Using a blood-perfused, isolated rabbit heart model, Leppo and Meerdink158 have shown that thallium has a higher transcapillary exchange rate than sestamibi, but sestamibi has a higher parenchymal cell permeability and higher volume of distribution than thallium. Despite the differences in kinetics between sestamibi and thallium, the regional myocardial uptake of the two tracers is similar. Thus, sestamibi is a marker of cellular viability as well as perfusion'59"160; published reports to date have demonstrated an excellent correlation between rest sestamibi uptake and severity of coronary artery stenosis as well as a good general correlation between sestamibi uptake and viability as assessed by wall motion.16" '162 In stunned but viable myocardium, sestamibi uptake should be an accurate marker of cellular viability, and this has been confirmed in several studies.163-'67 In experimentally induced stunned myocardium, the retention of sestamibi was comparable with 20Tl. 160, 163 In contrast, in regions with necrotic myocardium, the retention of sestamibi was negligible and paralleled indexes of viability as assessed by deoxyglucose uptake and histochemical staining rather than indexes of myocardial blood flow.160 Furthermore, after acute reperfusion in animal models, a close correlation between preliminary data suggest that low-dose dobutamine sestarnibi autoradiography images and pathological in-farct size has been demonstratedl64,l65 independent of regional blood flow.
In patients studied within the first week after thrombolytic therapy for acute myocardial infarction, sestamibi uptake correlated significantly with late ejection fraction measurements. 166 From the perspective of patient management decisions, the knowledge that a large portion of dysfunctional myocardium is viable rather than fibrotic can aid greatly in justifying a revascularization procedure in the high-risk patient with left ventricular dysfunction. However, the recommendation for myocardial revascularization in the patient with ventricular dysfunction is dependent on a number of considerations, of which myocardial viability is merely one. These considerations include the symptomatic status of the patient (including heart failure symptoms caused by ischemia as well as angina pectoris), coronary anatomy, and the severity of left ventricular dysfunction. Moreover, evidence of exercise-induced ischemia and hence, myocardium in jeopardy, identifies patients with multivessel disease and left ventricular dysfunction who are at high risk and who will benefit from revascularization.
In the majority of patients, once the issues of ischemic symptoms, suitable coronary artery anatomy, severity of ventricular dysfunction, and presence or absence of inducible ischemia have been clarified, the advisability of revascularization procedures may be readily determined. Although the demonstration of viable myocardium by one or more of the possible imaging modalities provides additional supportive information, it may not impact on management decisions importantly once these other considerations are addressed. On the other hand, in some patients, the accurate determination of the presence and extent of underperfused but viable myocardium is the primary issue that will dictate whether or not revascularization should be performed. It is these patients, in whom the differentiation of viable from nonviable myocardium is the overriding clinical concern, who continue to propel investigation in this field. These patients will be the source of interesting and exciting results over the next few years.
In the future, serial studies in patients with coronary artery disease should be performed to demonstrate whether hibernating myocardium is truly a chronic condition. In addition, adequate animal models should be developed that study the compensatory functional and metabolic alterations in hibernating myocardium. In the case of stunned myocardium, response of reperfused, asynergic myocardium to inotropic stimulation such as dopamine, isoproterenol, epinephrine, and dobutamine needs to be verified in greater numbers of human subjects. Further studies in a large number of patients evaluated before and after revascularization are clearly needed to establish more broadly applicable and reliable diagnostic algorithms using dobutamine echocardiography, thallium SPECT, or FDG PET in both hibernating and stunned myocardium. Although PET technology is superior to SPECT, it is very expensive, requires cyclotron technology, and is not readily available. On the other hand, thallium is widely available for clinical use and provides a less expensive alternative to PET assessment of regional metabolic activity. Recent publications suggest that either stress-redistribution-reinjection or rest-redistribution thallium protocols may provide cost-effective, efficient, accurate information regarding myocardial viability in the majority of patients with chronic ischemic left ventricular dysfunction. Therefore, only a small number of patients, in whom thallium results may be equivocal, would require metabolic assessment with PET. Hence, in the current era of cost containment, it would seem prudent for nuclear cardiology laboratories to use thallium for assessing myocardial viability. It is also important to determine whether another cost-effective modality, dobutamine echocardiography, provides information that compares favorably with the results of thallium scintigraphy. 
